Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Next-Generation Mass Spectrometer Market Poised To Hit $5.75 Billion By 2030 With A 9.8% CAGR
The next-generation mass spectrometer market has experienced substantial expansion over recent years. It is projected to grow from $3.6 billion in 2025 to $3.96 billion in 2026, registering a compound annual growth rate (CAGR) of 10.1%. Historically, this growth was influenced by factors including the constrained sensitivity and resolution of early mass spectrometers, reliance on conventional ion trap and quadrupole systems, burgeoning pharmaceutical and biotech research, an escalating demand for precise molecular analysis, and the substantial operational complexity and maintenance costs involved.
The next-generation mass spectrometer market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $5.75 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.8%. This projected increase during the forecast period is driven by factors such as the advancement of next-generation FT-MS and Orbitrap systems, the incorporation of AI-based data analysis, the broadening scope of clinical diagnostics and forensic uses, an increase in environmental monitoring and food safety assessments, and the need for high-throughput and automated mass spectrometry solutions. Significant trends expected during this period involve an increasing preference for high-resolution mass spectrometry, the integration of real-time data processing and analytical capabilities, growth in proteomics and metabolomics investigations, wider application in environmental and food testing, and an emphasis on making instruments smaller while improving their sensitivity.
Get A Free Sample Report With In-Depth Market Insights:
Next-Generation Mass Spectrometer Market Demand Drivers Opening New Revenue Streams
The increasing emphasis on personalized medicine is projected to propel the growth of the next-generation mass spectrometer market moving forward. Personalized medicine is a medical approach that customizes treatment and healthcare decisions for an individual’s unique genetic, environmental, and lifestyle factors to achieve more effective outcomes. The heightened focus on personalized medicine is due to the imperative to provide tailored treatments that improve patient outcomes, reduce side effects, and optimize healthcare efficiency based on individual genetic and lifestyle profiles. The next-generation mass spectrometer supports personalized medicine by delivering highly precise and comprehensive molecular analysis, which helps in identifying individual biomarkers, monitoring therapeutic responses, and guiding customized treatment plans for enhanced patient outcomes. For instance, in February 2024, according to a report from the Personalized Medicine Coalition, a US-based non-profit organization, the Food and Drug Administration (FDA), a US-based federal agency, authorized 16 new personalized medicines for rare disease patients in 2023, marking an increase from six in 2022. Therefore, the growing emphasis on personalized medicine will drive the growth of the next-generation mass spectrometer market.
Next-Generation Mass Spectrometer Market Segmentation: How Does The Market Break Down By Category?
The next-generation mass spectrometer market covered in this report is segmented –
1) By Type: Fourier Transform, Linear Ion Trap Mass Spectrometry, Other Types
2) By Application: Pharmaceuticals, Biotechnology, Clinical Diagnostics, Environmental Analysis, Food And Beverage Testing, Forensic Science, Other Applications
3) By End User: Research Laboratories, Academic Institutions, Pharmaceutical Companies, Biotechnology Firms, Clinical Laboratories, Government Agencies
Subsegments:
1) By Fourier Transform: Fourier Transform Ion Cyclotron Resonance (FT-ICR), Fourier Transform Orbitrap Mass Spectrometry, Hybrid FT-MS Systems, High-Resolution Accurate Mass (HRAM) FT-MS
2) By Linear Ion Trap Mass Spectrometry: Quadrupole Ion Trap, Three-Dimensional Linear Ion Trap, Dual-Pressure Linear Ion Trap, Linear Ion Trap-Time Of Flight (LIT-TOF) Hybrid
3) By Other Types: Time-Of-Flight Mass Spectrometry (TOF-MS), Quadrupole Mass Spectrometry, Orbitrap Mass Spectrometry (Non-FT Applications), Magnetic Sector Mass Spectrometry, Ion Mobility Mass Spectrometry, Hybrid Mass Spectrometers
Next-Generation Mass Spectrometer Market Trends Powering Strategic Industry Growth
Major companies operating in the next-generation mass spectrometer market are focusing on creating highly efficient instruments that allow researchers to examine complex biological samples with unparalleled precision and speed. These advancements aim to enhance biomarker discovery, aid in early disease detection, and accelerate the development of personalized therapies. For example, in June 2023, Thermo Fisher Scientific Inc., a US-based clinical research company, launched the Orbitrap Astral mass spectrometer, which features fast throughput, high sensitivity, and deep proteome coverage, representing one of the most significant mass spectrometry advancements in 15 years. This next-generation instrument empowers researchers to detect previously inaccessible low-abundance proteins by integrating ultra-fast scan speeds, exceptional sensitivity, and deep proteome coverage, substantially progressing large-scale proteomic analysis. It also includes enhanced ion transmission efficiency, an improved dynamic range, and up to four times higher throughput, thereby facilitating quicker biomarker discovery, precise quantification, and the development of targeted therapies across various diseases.
Next-Generation Mass Spectrometer Market Leading Companies And Competitive Benchmarking
Major companies operating in the next-generation mass spectrometer market are Hitachi Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., PerkinElmer Inc., Shimadzu Corporation, Waters Corporation, Bruker Corporation, HORIBA Ltd., JEOL Ltd., Rigaku Corporation, LECO Corporation, Hiden Analytical Ltd., Scion Instruments Ltd., MOBILion Systems Inc., Jiangsu Skyray Instrument Co. Ltd., Advion Inc., Postnova Analytics GmbH, Kore Technology Ltd., Variolytics GmbH, Spectroswiss, Excellims Corporation, 908 Devices Inc.
View The Full Next-Generation Mass Spectrometer Market Report:
Next-Generation Mass Spectrometer Market Top Region By Revenue And Market Share
North America was the largest region in the next-generation mass spectrometer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next-generation mass spectrometer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model